hashemi m, nadafzadeh n, imani mh, rajabi r, ziaolhagh s, bayanzadeh sd, norouzi r, rafiei r, koohpar zk, raei b, zandieh ma, salimimoghadam s, entezari m, taheriazam a, alexiou a, papadakis m, tan sc.  (2023).  targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.  - cell communication and signaling.  1-32. 

teck yew low, kok-yong chin, shing cheng tan.  (2023).  on the critical importance of meticulous data extraction for meta-analysis of genetic association study.  - archives of physiology and biochemistry.  1007-1008. 

asseri ah, alam mj, alzahrani f, khames a, pathan mt, abourehab mas, hosawi s, ahmed r, sultana sa, alam nf, alam nu, alam r, samad a, pokhrel s, kim jk, ahammad f, kim b, shing cheng tan.  (2022).  toward the identification of natural antiviral drug candidates against merkel cell polyomavirus: computational drug design approaches.  - pharmaceuticals.  1-23. 

sajad najafi, shing cheng tan, shahin aghamiri, pourya raee, zahra ebrahimi, zahra kargar jahromi, yazdan rahmati, javid sadri nahand, ahmad piroozmand, vahid jajarmi, hamed mirzaei.  (2022).  therapeutic potentials of crispr-cas genome editing technology in human viral infections.  - biomedicine & pharmacotherapy.  1-17. 

anastasiia dmytrivna shkodina, shing cheng tan, mohammad mehedi hasan, mai abdelgawad, hitesh chopra, muhammad bilal, dmytro ivanovych boiko, kateryna anatoliivna tarianyk, athanasios alexiou.  (2022).  roles of clock genes in the pathogenesis of parkinson's disease.  - ageing research reviews.  1-16. 

hilary sito & shing cheng tan.  (2024).  genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.  - molecular biology reports.  1-25. 

hilary sito, mohamad ayub khan sharzehan, md asiful islam, shing cheng tan.  (2024).  genetic variants associated with response to platinum-based chemotherapy in non-small cell lung cancer patients: a field synopsis and meta-analysis.  - british journal of biomedical science.  1-12. 

shing cheng tan, wen tsin poh, audrey chee hui yong, eng wee chua, der jiun ooi, rozi mahmud, muthukkumaran thiagarajan, johnson stanslas.  (2023).  challenges and strategies for improving access to cancer drugs in malaysia: summary of opinions expressed at the 2nd macr international scientific conference 2022.  - cancer management and research.  851-862. 

eng wee chua, audrey chee hui yong, der jiun ooi, jonathan chee woei lim, jhi biau foo, gopal natesan, sau har lee, yuan seng wu, shing cheng tan, johnson stanslas.  (2023).  a summary of the second macr international scientific conference (2nd msc).  - oncologie.  333-334. 

shing cheng tan.  (2019).  use of arbitrary reference genes may lead to misleading conclusions.  - gynecologic and obstetric investigation.  519-520. 

hilary sito, mohamad ayub khan sharzehan, md asiful islam, shing cheng tan.  (2024).  genetic variants associated with response to platinum-based chemotherapy in non-small cell lung cancer patients: a field synopsis and meta-analysis.  - british journal of biomedical science.  1-12. 

hilary sito & shing cheng tan.  (2024).  genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.  - molecular biology reports.  1-25. 

teck yew low, kok-yong chin, shing cheng tan.  (2023).  on the critical importance of meticulous data extraction for meta-analysis of genetic association study.  - archives of physiology and biochemistry.  1007-1008. 

hashemi m, nadafzadeh n, imani mh, rajabi r, ziaolhagh s, bayanzadeh sd, norouzi r, rafiei r, koohpar zk, raei b, zandieh ma, salimimoghadam s, entezari m, taheriazam a, alexiou a, papadakis m, tan sc.  (2023).  targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.  - cell communication and signaling.  1-32. 

eng wee chua, audrey chee hui yong, der jiun ooi, jonathan chee woei lim, jhi biau foo, gopal natesan, sau har lee, yuan seng wu, shing cheng tan, johnson stanslas.  (2023).  a summary of the second macr international scientific conference (2nd msc).  - oncologie.  333-334. 

shing cheng tan, hui-min neoh, mia yang ang, mohamad ayub khan sharzehan, nursyazwani omar, and teck yew low.  (2022).  regionalized management of medicine.  - .  28. 

shing cheng tan, hui-min neoh, mia yang ang, mohamad ayub khan sharzehan, nursyazwani omar, and teck yew low.  (2022).  regionalized management of medicine.  - .  28. 

saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - .  244. 

tan shing cheng;a. rahman bin a. jamal;noraidatulakma binti abdullah @ muda;nadiah binti abu.  (2025).  identification, validation and functional characterization of genetic variants associated with resistance to platinum-based therapy among non-small cell lung cancer patients in malaysia.  - .  . 

hilary sito, sharzehan mohamad ayub khan, dr. tan shing cheng.  (2022).  meta-analysis in medical research.  - .  1-5. 

tan shing cheng;a. rahman bin a. jamal;norlia bt. abdullah;nazihah binti abd. jalal;noraidatulakma binti abdullah @ muda;ezanee azlina binti mohamad hanif;nurul syakima binti ab mutalib.  (2021).  functional polymorphisms in microrna genes and their influence on breast cancer susceptibility.  - .  . 

nurul syakima ab mutalib, tan shing cheng, siti aishah sulaiman, rahman jamal.  (2020).  adakah anda mewarisi gen untuk risiko serangan jantung?.  - .  1. 

mira farzana binti mohamad mokhtar & dr. tan shing cheng.  (2020).  microrna at a glance.  - .  1-3. 

hashemi m, nadafzadeh n, imani mh, rajabi r, ziaolhagh s, bayanzadeh sd, norouzi r, rafiei r, koohpar zk, raei b, zandieh ma, salimimoghadam s, entezari m, taheriazam a, alexiou a, papadakis m, tan sc.  (2023).  targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.  - cell communication and signaling.  1-32. 

teck yew low, kok-yong chin, shing cheng tan.  (2023).  on the critical importance of meticulous data extraction for meta-analysis of genetic association study.  - archives of physiology and biochemistry.  1007-1008. 

asseri ah, alam mj, alzahrani f, khames a, pathan mt, abourehab mas, hosawi s, ahmed r, sultana sa, alam nf, alam nu, alam r, samad a, pokhrel s, kim jk, ahammad f, kim b, shing cheng tan.  (2022).  toward the identification of natural antiviral drug candidates against merkel cell polyomavirus: computational drug design approaches.  - pharmaceuticals.  1-23. 

sajad najafi, shing cheng tan, shahin aghamiri, pourya raee, zahra ebrahimi, zahra kargar jahromi, yazdan rahmati, javid sadri nahand, ahmad piroozmand, vahid jajarmi, hamed mirzaei.  (2022).  therapeutic potentials of crispr-cas genome editing technology in human viral infections.  - biomedicine & pharmacotherapy.  1-17. 

anastasiia dmytrivna shkodina, shing cheng tan, mohammad mehedi hasan, mai abdelgawad, hitesh chopra, muhammad bilal, dmytro ivanovych boiko, kateryna anatoliivna tarianyk, athanasios alexiou.  (2022).  roles of clock genes in the pathogenesis of parkinson's disease.  - ageing research reviews.  1-16. 

hilary sito & shing cheng tan.  (2024).  genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.  - molecular biology reports.  1-25. 

hilary sito, mohamad ayub khan sharzehan, md asiful islam, shing cheng tan.  (2024).  genetic variants associated with response to platinum-based chemotherapy in non-small cell lung cancer patients: a field synopsis and meta-analysis.  - british journal of biomedical science.  1-12. 

shing cheng tan, wen tsin poh, audrey chee hui yong, eng wee chua, der jiun ooi, rozi mahmud, muthukkumaran thiagarajan, johnson stanslas.  (2023).  challenges and strategies for improving access to cancer drugs in malaysia: summary of opinions expressed at the 2nd macr international scientific conference 2022.  - cancer management and research.  851-862. 

eng wee chua, audrey chee hui yong, der jiun ooi, jonathan chee woei lim, jhi biau foo, gopal natesan, sau har lee, yuan seng wu, shing cheng tan, johnson stanslas.  (2023).  a summary of the second macr international scientific conference (2nd msc).  - oncologie.  333-334. 

shing cheng tan.  (2019).  use of arbitrary reference genes may lead to misleading conclusions.  - gynecologic and obstetric investigation.  519-520. 

hilary sito, mohamad ayub khan sharzehan, md asiful islam, shing cheng tan.  (2024).  genetic variants associated with response to platinum-based chemotherapy in non-small cell lung cancer patients: a field synopsis and meta-analysis.  - british journal of biomedical science.  1-12. 

hilary sito & shing cheng tan.  (2024).  genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.  - molecular biology reports.  1-25. 

teck yew low, kok-yong chin, shing cheng tan.  (2023).  on the critical importance of meticulous data extraction for meta-analysis of genetic association study.  - archives of physiology and biochemistry.  1007-1008. 

hashemi m, nadafzadeh n, imani mh, rajabi r, ziaolhagh s, bayanzadeh sd, norouzi r, rafiei r, koohpar zk, raei b, zandieh ma, salimimoghadam s, entezari m, taheriazam a, alexiou a, papadakis m, tan sc.  (2023).  targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.  - cell communication and signaling.  1-32. 

eng wee chua, audrey chee hui yong, der jiun ooi, jonathan chee woei lim, jhi biau foo, gopal natesan, sau har lee, yuan seng wu, shing cheng tan, johnson stanslas.  (2023).  a summary of the second macr international scientific conference (2nd msc).  - oncologie.  333-334. 

shing cheng tan, hui-min neoh, mia yang ang, mohamad ayub khan sharzehan, nursyazwani omar, and teck yew low.  (2022).  regionalized management of medicine.  - .  28. 

shing cheng tan, hui-min neoh, mia yang ang, mohamad ayub khan sharzehan, nursyazwani omar, and teck yew low.  (2022).  regionalized management of medicine.  - .  28. 

saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - .  244. 

tan shing cheng;a. rahman bin a. jamal;noraidatulakma binti abdullah @ muda;nadiah binti abu.  (2025).  identification, validation and functional characterization of genetic variants associated with resistance to platinum-based therapy among non-small cell lung cancer patients in malaysia.  - .  . 

hilary sito, sharzehan mohamad ayub khan, dr. tan shing cheng.  (2022).  meta-analysis in medical research.  - .  1-5. 

tan shing cheng;a. rahman bin a. jamal;norlia bt. abdullah;nazihah binti abd. jalal;noraidatulakma binti abdullah @ muda;ezanee azlina binti mohamad hanif;nurul syakima binti ab mutalib.  (2021).  functional polymorphisms in microrna genes and their influence on breast cancer susceptibility.  - .  . 

nurul syakima ab mutalib, tan shing cheng, siti aishah sulaiman, rahman jamal.  (2020).  adakah anda mewarisi gen untuk risiko serangan jantung?.  - .  1. 

mira farzana binti mohamad mokhtar & dr. tan shing cheng.  (2020).  microrna at a glance.  - .  1-3.